Cargando…
Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging
BACKGROUND: Novel treatment strategies in Ewing sarcoma include targeted cellular therapies. Preclinical in vivo models are needed that reflect their activity against systemic (micro)metastatic disease. METHODS: Whole-body magnetic resonance imaging (WB-MRI) was used to monitor the engraftment and d...
Autores principales: | Liebsch, L, Kailayangiri, S, Beck, L, Altvater, B, Koch, R, Dierkes, C, Hotfilder, M, Nagelmann, N, Faber, C, Kooijman, H, Ring, J, Vieth, V, Rossig, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738111/ https://www.ncbi.nlm.nih.gov/pubmed/23839490 http://dx.doi.org/10.1038/bjc.2013.356 |
Ejemplares similares
-
The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
por: Kailayangiri, S, et al.
Publicado: (2012) -
PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death
por: Hotfilder, M, et al.
Publicado: (2005) -
Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin
por: García-Santos, G, et al.
Publicado: (2012) -
Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma
por: Kang, Zhigang, et al.
Publicado: (2015) -
Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours
por: White, D E, et al.
Publicado: (2010)